ESR1 and prostate cancer: From a large compendium of ERα-regulated non-coding transcripts, we selected NEAT1 for a detailed biochemical and in vivo evaluation, based on an in silico approach that demonstrated a strong association of NEAT1 with prostate cancer progression.